Registration for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 24, 2014
April 17, 2020
74d2bf28-3d33-408f-9b37-e47a144fa9bc
Related Documents
Facility Definition Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentMay 10, 2018Center for Drug Evaluation and Research
Adverse Event Reporting for Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act
Guidance DocumentOctober 8, 2015Center for Drug Evaluation and Research
Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act”
Guidance DocumentJanuary 3, 2017Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.